BioPharma Today

How's Your Guanxi?

You may have heard of the Chinese business concept of guanxi, but do you really understand it? The term, loosely defined as "relationship," can be maligned in the West, but there's more to it than cronyism.

A Race for Growth: Leveraging Cross Border Opportunities

UCLA's Anderson School of Management, will host the Wilbur K. Woo Greater China Business Conference on March 4, 2011.

Have you seen our M.E.N.A Coverage?

Check out these headlines covering the Middle East and North Africa (MENA) in "PharmAsia News".

CMS Administrator: The Pick Has Been Made, But Who Is It?

Full article preview from The RPM Report January 27, 2009

The Obama Administration is understood to have made its choice for the next head of the Medicare agency. Will it be an MD? Find out now...
 

Race For White Oak Almost Over: Will It End With Sharfstein Or Califf At FDA?

Article preview from "The Pink Sheet" January 20, 2009

Find out why The Senate confirmation of a permanent FDA commissioner could come as early as March now that the Obama transition team has apparently concluded its search for Andrew von Eschenbach's successor...

FDA Commissioner Update: Califf's Name Emerges But Is Sharfstein the Pick?

Full article reprinted from The RPM Report January 20, 2009

We know you've been waiting on the edge of your seat so we thought we'd send you an update. We've heard that Duke researcher Robert Califf and Baltimore Commissioner of Health Joshua Sharfstein have been tapped, at the very least, for interviews. Read more now...

The Return of Henney?

Full article reprinted from The RPM Report January 13, 2009

Former FDA Commissioner Jane Henney’s name has surfaced for a possible return to FDA. Whether she’s in the running for the job, or it’s just the Washington rumor mill in action, she would be a safe pick for the incoming administration. Read more about it here...
 

Season's Greetings From BioPharma Today!

Happy Holidays

In the spirit of the season, BioPharma Today will not be posting new content on December 30.

We will resume new posts starting January 6, 2009. We wish all our readers a joyful holiday season and all the best for 2009.

Economic Forecast for Pharma: Winter Weather Advisory Ahead

Article preview from "IN VIVO" December 23, 2008

Pharma has weathered its share of economic downturns, but the data shows that the industry could be in for a tough winter. Prolonged cutbacks by consumers failing to refill prescriptions in tough economic times could become yet another obstacle for drug manufacturers already facing plenty of challenges in the coming year in the form of patent expirations, lackluster pipelines and stricter regulatory oversight. Find out more...

Special Annoucement: The IN VIVO Blog Wants you to Particapate in a Special Vote

It's time to have your say, The IN VIVO Blog wants readers to particapate in a poll for the Deal of the Year. This feature is live now! Please vote.

Get your friends and colleagues and families to vote. Click here to access the voting poll.